Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
出版年份 2021 全文链接
标题
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
作者
关键词
-
出版物
Diabetes & Metabolism Journal
Volume 45, Issue 6, Pages 909-920
出版商
Korean Diabetes Association
发表日期
2021-06-04
DOI
10.4093/dmj.2020.0168
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat
- (2018) Sin Young Choi et al. BIOMEDICINE & PHARMACOTHERAPY
- Epigallocatechin gallate reverses cTnI-low expression-induced age-related heart diastolic dysfunction through histone acetylation modification
- (2017) Bo Pan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer
- (2017) Besma Abbaoui et al. Journal of Proteomics
- Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni
- (2017) Letícia Anderson et al. PLoS Neglected Tropical Diseases
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
- (2016) Eunjo Lee et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
- (2016) Ravi Shankar Singh et al. Scientific Reports
- Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
- (2015) Youfang Chen et al. Cardiovascular Diabetology
- Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat
- (2015) Sabbir Khan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2
- (2015) Hao Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway
- (2015) Guoguo Shang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Unknown
- (2015) Lili Kong et al. MOLECULAR MEDICINE
- Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice
- (2012) Wenpeng Cui et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Role of the TGF-β/BMP-7/Smad pathways in renal diseases
- (2012) Xiao-Ming Meng et al. CLINICAL SCIENCE
- Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
- (2012) Wenpeng Cui et al. Oxidative Medicine and Cellular Longevity
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- The BMP-7–Smad1/5/8 Pathway Promotes Kidney Repair After Obstruction Induced Renal Injury
- (2011) Scott R. Manson et al. JOURNAL OF UROLOGY
- Protective effect of sulforaphane against oxidative stress: Recent advances
- (2010) Carlos Enrique Guerrero-Beltrán et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Epigenetic Regulation of BMP7 in the Regenerative Response to Ischemia
- (2008) T. Marumo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now